Login  

 

The article you requested is

Editorial: Funding, Conflicts, and Paradigms

J Clin Psychiatry 2005;66(5):554

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

This past February and March, the New York Times published an article (Gardiner Harris and Alex Berenson, “10 Voters on Panel Backing Pain Pills Had Industry Ties,” Feb 25, 2005) and subsequent editorial (March 4) concerning an FDA Advisory Panel that recommended marketing of several COX-2 inhibitor analgesics. They cited the Center for Science in the Public Interest, an advocacy group, which found that 10 of the 37 panel members had consulted for or received research support from manufacturers of the drugs being reviewed. The Times then observed that, had the votes of the 10 scientists with industry connections been excluded, the panel would have voted to withdraw one of the drugs and recommended blocking the return of another.​​